Seven additional phase 3 readouts are expected throughout this year, covering a range of conditions including type 2 diabetes, obstructive sleep apnea, chronic low back pain, cardiovascular outcomes, and metabolic dysfunction-associated steatotic liver disease
GLP-1s mimic a hormone produced in the gut to suppress a person's appetite and regulate blood sugar
Estrogen plays a key role in regulating osteoclast activity
This flexibility is an advantage for people who have found their optimal technique through experimentation
The Medicines and Healthcare products Regulatory Agency (MHRA) and manufacturers provide detailed guidance on administration techniques, which should be reviewed with your healthcare provider or diabetes specialist nurse before commencing treatment
The SELECT trial provided the first evidence of kidney protection with GLP-1RA treatment in individuals without diabetes, although this was a prespecified secondary endpoint